日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Serratia proteamaculans Fe/S biogenesis protein NfuA (nfuA) CSB-YP421585STJ
CSB-EP421585STJ
CSB-BP421585STJ
CSB-MP421585STJ
CSB-EP421585STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans Dihydroxy-acid dehydratase (ilvD), partial CSB-YP421586STJ
CSB-EP421586STJ
CSB-BP421586STJ
CSB-MP421586STJ
CSB-EP421586STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans Regulator of ribonuclease activity A (rraA) CSB-YP421587STJ
CSB-EP421587STJ
CSB-BP421587STJ
CSB-MP421587STJ
CSB-EP421587STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans 2,3-bisphosphoglycerate-independent phosphoglycerate mutase (gpmI), partial CSB-YP421588STJ
CSB-EP421588STJ
CSB-BP421588STJ
CSB-MP421588STJ
CSB-EP421588STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans Nucleoid occlusion factor SlmA (slmA) CSB-YP421589STJ
CSB-EP421589STJ
CSB-BP421589STJ
CSB-MP421589STJ
CSB-EP421589STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans Der GTPase-activating protein YihI (yihI) CSB-YP421590STJ
CSB-EP421590STJ
CSB-BP421590STJ
CSB-MP421590STJ
CSB-EP421590STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans Protein viaA (viaA) CSB-YP421591STJ
CSB-EP421591STJ
CSB-BP421591STJ
CSB-MP421591STJ
CSB-EP421591STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia akari UDP-3-O-acylglucosamine N-acyltransferase (lpxD) CSB-YP421592RIL
CSB-EP421592RIL
CSB-BP421592RIL
CSB-MP421592RIL
CSB-EP421592RIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia akari 50S ribosomal protein L9 (rplI) CSB-YP421593RIL
CSB-EP421593RIL
CSB-BP421593RIL
CSB-MP421593RIL
CSB-EP421593RIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia akari Prolipoprotein diacylglyceryl transferase (lgt), partial CSB-YP421594RIL1
CSB-EP421594RIL1
CSB-BP421594RIL1
CSB-MP421594RIL1
CSB-EP421594RIL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia akari Cysteine--tRNA ligase (cysS) CSB-YP421595RIL
CSB-EP421595RIL
CSB-BP421595RIL
CSB-MP421595RIL
CSB-EP421595RIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia akari Probable GTP-binding protein EngB (engB) CSB-YP421596RIL
CSB-EP421596RIL
CSB-BP421596RIL
CSB-MP421596RIL
CSB-EP421596RIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia akari Protein translocase subunit SecF (secF), partial CSB-YP421597RIL1
CSB-EP421597RIL1
CSB-BP421597RIL1
CSB-MP421597RIL1
CSB-EP421597RIL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia akari 30S ribosomal protein S12 (rpsL) CSB-YP421598RIL
CSB-EP421598RIL
CSB-BP421598RIL
CSB-MP421598RIL
CSB-EP421598RIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia akari DNA-directed RNA polymerase subunit beta (rpoB), partial CSB-YP421599RIL
CSB-EP421599RIL
CSB-BP421599RIL
CSB-MP421599RIL
CSB-EP421599RIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia akari Uridylate kinase (pyrH) CSB-YP421600RIL
CSB-EP421600RIL
CSB-BP421600RIL
CSB-MP421600RIL
CSB-EP421600RIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia akari Chaperone protein hscA homolog (hscA), partial CSB-YP421601RIL
CSB-EP421601RIL
CSB-BP421601RIL
CSB-MP421601RIL
CSB-EP421601RIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia akari Elongation factor P (efp) CSB-YP421602RIL
CSB-EP421602RIL
CSB-BP421602RIL
CSB-MP421602RIL
CSB-EP421602RIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia akari Elongation factor 4 (lepA), partial CSB-YP421603RIL
CSB-EP421603RIL
CSB-BP421603RIL
CSB-MP421603RIL
CSB-EP421603RIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia akari ATP-dependent protease ATPase subunit HslU (hslU) CSB-YP421604RIL
CSB-EP421604RIL
CSB-BP421604RIL
CSB-MP421604RIL
CSB-EP421604RIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×